Tag: Diadem

Biomarker, Innovation

Diadem raises funding to develop Alzheimer’s detection test

March 29, 2022


Diagnostic testing firm Diadem has raised $10.97m (€10m) in the first tranche of its equity funding for its AlzoSure Predict prognostic blood test for Alzheimer’s disease (AD). New investor CDP Venture Capital and current investor Panakès Partners led the financing […]